Echevarria Joseph 4

What Happened
Joseph Echevarria, a member of Pfizer's Board of Directors, was granted 1,904.076 units that represent phantom shares of common stock on 2026-06-26. The units were valued at $24.29 each for a total grant value of $46,250. The Form 4 reports this as an award/grant (transaction code A) of a derivative security, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-26; Form 4 filed: 2026-06-30 (filed within the 2 business-day window).
• Grant: 1,904.076 units at $24.29 per unit; total reported value $46,250.
• Security type: Derivative units (phantom shares) — each unit equals one phantom share (Footnote F1).
• Vesting/settlement: These units are deferred director compensation and may be settled in cash or common stock at the director’s election after retirement from the board (Footnote F2).
• Shares owned after transaction: Not disclosed in this Form 4.

Context
This is a deferred compensation award to a director (common for board pay) rather than a market purchase or sale; it does not by itself indicate buying or selling sentiment. Phantom-share awards accrue value and dividend equivalents and are typically paid out later in cash or stock per the director’s election.